Gene mutations in small-cell lung cancer (SCLC): Results of a panel of 6 genes in a cohort of Italian patients

Lung Cancer

Volumn 86, Issue 3, 2014, Pages 324-328

  Bordi, Paola ^a   Tiseo, Marcello ^a   Barbieri, Fausto ^b   Bavieri, Mario ^b   Sartori, Giuliana ^c   Marchetti, Antonio ^d   Buttitta, Fiamma ^d   Bortesi, Beatrice ^a   Ambrosini Spaltro, Andrea ^e   Gnetti, Letizia ^a   Silini, Enrico Maria ^a   Ardizzoni, Andrea ^a   Rossi, Giulio ^b  

^a UNIVERSITY HOSPITAL OF PARMA   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^c S MARIA NUOVA HOSPITAL   (Italy)

^d UNIVERSITY OF CHIETI   (Italy)

^e CENTRAL HOSPITAL OF BOLZANO   (Italy)

Author keywords

BRAF; C KIT; C MET; EGFR; Gene mutations; KRAS; PDGFRa; SCLC

Indexed keywords

B RAF KINASE; CD56 ANTIGEN; CHROMOGRANIN; EPIDERMAL GROWTH FACTOR RECEPTOR; FORMALDEHYDE; K RAS PROTEIN; PARAFFIN; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PROTEIN BCL 2; PROTEIN P63; SCATTER FACTOR RECEPTOR; STEM CELL FACTOR; SYNAPTOPHYSIN; THYROID TRANSCRIPTION FACTOR 1;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; DNA EXTRACTION; EXON; FEMALE; GENE DELETION; GENE MUTATION; GENE SEQUENCE; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; ITALIAN (CITIZEN); MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMALL CELL LUNG CANCER; VERY ELDERLY; WILD TYPE;

EID: 84964222371     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2014.10.002     Document Type: Article

References (34)

1. Siegel R., Ma J., Zou Z., Jemal A. Cancer Statistics, 2014. CA Cancer J Clin 2014, 64:9-29.
2. Früh M., De Ruysscher D., Popat S., Crinò L., Peters S., Felip E. Small-cell lung cancer (SCLC): ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 2013, 24(suppl 6):vi99-vi105.
3. Jackman D.M., Johnson B.E. Small-Cell Lung Cancer. Lancet 2005, 366:1385-1396.
4. Zhang Y., He J. The development of targeted therapy in small cell lung cancer. J Thorac Dis 2013, 5:538-548.
5. Wistuba I.I., Gazdar A.F., Minna J.D. Molecular genetics of small cell lung carcinoma. Semin Oncol 2001, 28:3-13.
6. Travis WD, Brambilla E, Müller-Hermelink HK and Harris CC. Pathology and genetics of tumors of the lung, pleura, thymus and heart. Third edition. WHO classification of Tumors, Volume 10. IARC.
7. Therasse P., Arbuck S.G., Eisenhauer E.A., Wanders J., Kaplan R.S., Rubinstein L., et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000, 92:206-216.
8. Zakowski M.F., Ladanyi M., Kris M.G. EGFR mutations in small-cell lung cancers in patients who have never smoked. N Engl J Med 2006, 355:213-215. Memorial Sloan-Kettering Cancer Center Lung Cancer OncoGenome Group.
9. Morinaga R., Okamoto I., Furuta K., Kawano Y., Sekijima M., Dote K., et al. Sequential occurrence of non-small cell and small cell lung cancer with the same EGFR mutation. Lung Cancer 2007, 58:411-413.
10. Sequist L.V., Waltman B.A., Dias-Santagata D., Digumarthy S., Turke A.B., Fidias P., et al. Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors. Sci Transl Med 2011, 3:75ra26.
11. Shiao T-H., Chang Y-L., Yu C-J., Chang Y-C., Hsu Y-C., Chang S-H., et al. Epidermal growth factor receptor mutations in small cell lung cancer. A brief report. J Thorac Oncol 2011, 6:195-198.
12. Lu H.Y., Sun W.Y., Chen B., Zhang Y.P., Cai J.F., Su D., et al. Epidermal growth factor receptor mutations in small cell lung cancer patients who received surgical resection in China. Neoplasma 2012, 59:100-104.
13. Tatematsu A., Shimizu J., Murakami Y., Horio Y., Nakamura S., Hida T., et al. Epidermal growth factor receptor mutations in small cell lung cancer. Clin Cancer Res 2008, 14:6092-6096.
14. Fukui T., Tsuta K., Furuta K., Watanabe S., Asamura H., Ohe Y., et al. Epidermal growth factor receptor mutation status and clinicopathological features of combined small cell carcinoma with adenocarcinoma of the lung. Cancer Sci 2007, 98:1714-1719.
15. Wakuda K., Kenmotsu H., Serizawa M., Koh Y., Isaka M., Takahashi S., et al. Molecular profiling of small cell lung cancer in a Japanese cohort. Lung Cancer 2014, 84:139-144.
16. Ou S.H., Ziogas A., Zell J.A. Prognostic factors for survival in extensive stage small cell lung cancer (ED-SCLC): the importance of smoking history, socioeconomic and marital status, and ethnicity. J Thorac Oncol 2009, 4:37-43.
17. Fraire A.E., Johnson E.H., Yesner R., Zhang X.B., Spjut H.J., Greenberg S.D. Prognostic significance of histopathologic subtype and stage in small cell lung cancer. Hum Pathol 1992, 23:520-528.
18. Mangum M.D., Greco F.A., Hainsworth J.D., Hande K.R., Johnson D.H. Combined small-cell and non-small-cell lung cancer. J Clin Oncol 1989, 7:607-612.
19. Okamoto I., Araki J., Suto R., Shimada M., Nakagawa K., Fukuoka M. EGFR mutation in gefitinib-responsive small-cell lung cancer. Ann Oncol 2006, 17:1028-1029.
20. Varghese A.M., Zakowski M.F., Yu H.A., Won H.H., Riely G.J., Krug L.M., et al. Small-cell lung cancer in patients who never smoked cigarettes. J Thorac Oncol 2014, 9:892-896.
21. Moore A.M., Einhorn L.H., Estes D., Govindan R., Axelson J., Vinson J., et al. Gefitinib in patients with chemosensitive and chemo-refractory relapsed small cell cancers: a Hoosier Oncology Group phase II trial. Lung Cancer 2006, 52:93-97.
22. Ma P.C., Kijima T., Maulik G., Fox E.A., Sattler M., Griffin J.D., et al. C-Met mutational analysis in small cell lung cancer: novel juxtamembrane domain mutations regulating cytoskeletal functions. Cancer Res 2003, 63:6272-6281.
23. Voortman J., Harada T., Chang R.P., Killian J.K., Suuriniemi M., Smith W.I., et al. Detection and therapeutic implications of c-Met mutations in small cell lung cancer and neuroendocrine tumors. Curr Pharm Des 2013, 19:833-840.
24. Peifer M., Fernández-Cuesta L., Sos M.L., George J., Seidel D., Kasper L.H., et al. Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer. Nat Genet 2012, 44:1104-1110.
25. Arriola E., Cañadas I., Arumí-Uría M., Dómine M., Lopez-Vilariño J.A., Arpí O., et al. MET phosphorylation predicts poor outcome in small cell lung carcinoma and its inhibition blocks HGF-induced effects in MET mutant cell lines. Br J Cancer 2011, 105:814-823.
26. Cañadas I., Rojo F., Taus Á., Arpí O., Arumí-Uría M., Pijuan L., et al. Targeting epithelial-to-mesenchymal transition with Met inhibitors reverts chemoresistance in small cell lung cancer. Clin Cancer Res 2014, 20:938-950.
27. Byers L.A., Wang J., Nilsson M.B., Fujimoto J., Saintigny P., Yordy J., et al. Proteomic profiling identifies dysregulated pathways in small cell lung cancer and novel therapeutic targets including PARP1. Cancer Discov 2012, 2:798-811.
28. Rudin C.M., Durinck S., Stawiski E.W., Poirier J.T., Modrusan Z., Shames D.S., et al. Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer. Nat Genet 2012, 44:1111-1116.
29. Krug L.M., Crapanzano J.P., Azzoli C.G., Miller V.A., Rizvi N., Gomez J., et al. Imatinib mesylate lacks activity in small cell lung carcinoma expressing c-kit protein: a phase II clinical trial. Cancer 2005, 103:2128-2131.
30. Xuan H., Jingshu G., Fang Y., Na L., Xiaolin S., Zhaoyang Y., et al. Somatic mutations of KIT is rare in small cell lung cancer patients from Northeast China. Histol Histopathol 2014, 29:273-278.
31. Boldrini L., Ursino S., Gisfredi S., Faviana P., Donati V., Camacci T., et al. Expression and mutational status of c-kit in small-cell lung cancer: prognostic relevance. Clin Cancer Res 2004, 10:4101-4108.
32. Lu H.Y., Zhang G., Cheng Q.Y., Chen B., Cai J.F., Wang X.J., et al. Expression and mutation of the c-kit gene and correlation with prognosis of small cell lung cancer. Oncol Lett 2012, 4:89-93.
33. Terada T. An immunohistochemical and molecular genetic analysis of KIT and PDGFRA in small cell lung carcinoma in Japanese. Int J Clin Exp Pathol 2012, 5:331-338.
34. Yamamoto H., Shigematsu H., Nomura M., Lockwood W.W., Sato M., Okumura N., et al. PIK3CA mutations and copy number gains in human lung cancers. Cancer Res 2008, 68:6913-6921.